Perioperative Opioids and Colorectal Cancer Recurrence: A Systematic Review of the Literature

References

• Siegel RL , MillerKD , JemalA . Cancer statistics, 2018 . CA Cancer J. Clin.68 ( 1 ), 7 – 30 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Desborough JP . The stress response to trauma and surgery . Br. J. Anaesth.85 ( 1 ), 109 – 117 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Cata JP . Can the perioperative anesthesia care of patients with cancer affect their long-term oncological outcomes?Anesth. Analg.124 ( 5 ), 1383 – 1384 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Ciechanowicz SJ , MaD . Anaesthesia for oncological surgery – can it really influence cancer recurrence?Anaesthesia71 ( 2 ), 127 – 131 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Cata JP , BugadaD , de AndresJ . Opioid less perioperative care . Minerva Anestesiol.83 ( 3 ), 315 – 320 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Lennon FE , MirzapoiazovaT , MambetsarievBet al. The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and epithelial mesenchymal transition (EMT) in human lung cancer . PLoS ONE9 ( 3 ), e91577 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mathew B , LennonF , SieglerJet al. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation . Anesth. Analg.112 ( 3 ), 558 – 567 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wu Q , ChenX , WangJet al. Nalmefene attenuates malignant potential in colorectal cancer cell via inhibition of opioid receptor . Acta Biochim. Biophys. Sin. (Shanghai)50 ( 2 ), 156 – 163 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Lennon FE , MirzapoiazovaT , MambetsarievB , SalgiaR , MossJ , SingletonPA . Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis . Anesthesiology116 ( 4 ), 857 – 867 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Cao L-H , LiH-T , LinW-Qet al. Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts . Sci. Rep.6 ( 1 ), 18706 ( 2016 ).
   PubMedGoogle Scholar
• Lazarczyk M , MatyjaE , LipkowskiAW . A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro . Peptides31 ( 8 ), 1606 – 1612 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Chen Q , LiP , LiP , XuY , LiY , TangBO . Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen-activated protein kinase signalling pathway . Oncol. Rep.33 ( 2 ), 840 – 848 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Niu DG , PengF , ZhangWet al. Morphine promotes cancer stem cell properties, contributing to chemoresistance in breast cancer . Oncotarget6 ( 6 ), 3963 – 3976 ( 2015 ).
   PubMedGoogle Scholar
• Vassou D , NotasG , HatzoglouA , CastanasE , KampaM . Opioids increase bladder cancer cell migration via bradykinin B2 receptors . Int. J. Oncol.39 ( 3 ), 697 – 707 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bimonte S , BarbieriA , ReaDet al. Morphine promotes tumor angiogenesis and increases breast cancer progression . Biomed Res. Int.2015 , 161508 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zagon IS , RahnKA , MclaughlinPJ . Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells . Neuropeptides41 ( 6 ), 441 – 452 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Ahmad A , ScottAJ , SongE-Ket al. Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model . PLoS ONE12 ( 11 ), ( 2017 ).
   Web of Science ®Google Scholar
• Bahrami A , KhazaeiM , HasanzadehMet al. Therapeutic potential of targeting PI3K/AKT pathway in treatment of colorectal cancer: rational and progress . J. Cell. Biochem.119 ( 3 ), 2460 – 2469 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Carr DJ , GebhardtBM , PaulD . Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity . J. Pharmacol. Exp. Ther.264 ( 3 ), 1179 – 1186 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Zhang EY , XiongJ , ParkerBLet al. Depletion and recovery of lymphoid subsets following morphine administration . Br. J. Pharmacol.164 ( 7 ), 1829 – 1844 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zagon IS , DonahueRN , BonneauRH , MclaughlinPJ . B lymphocyte proliferation is suppressed by the opioid growth factor–opioid growth factor receptor axis: implication for the treatment of autoimmune diseases . Immunobiology216 ( 1-2 ), 173 – 183 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Toskulkao T , PornchaiR , AkkarapatumwongV , VatanatunyakumS , GovitrapongP . Alteration of lymphocyte opioid receptors in methadone maintenance subjects . Neurochem. Int.56 ( 2 ), 285 – 290 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bergquist J , TarkowskiA , EwingA , EkmanR . Catecholaminergic suppression of immunocompetent cells . Immunol. Today19 ( 12 ), 562 – 567 ( 1998 ).
   PubMedGoogle Scholar
• Liang-Suo J , Gomez-FloresR , WeberRJ . Immunosuppression induced by central action of morphine is not blocked by mifepristone (RU 486) . Life Sci.71 ( 22 ), 2595 – 2602 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Ishikawa M , TannoK , KamoA , TakayanagiY , SasakiK . Enhancement of tumor growth by morphine and its possible mechanism in mice . Biol. Pharm. Bull.16 ( 8 ), 762 – 766 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Ohara T , ItohT , TakahashiM . Immunosuppression by morphine-induced lymphocyte apoptosis: is it a real issue?Anesth. Analg.101 ( 4 ), 1117 – 1122 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Alexander M , DanielT , ChaudryIH , SchwachaMG . Opiate analgesics contribute to the development of post-injury immunosuppression . J. Surg. Res.129 ( 1 ), 161 – 168 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Roy S , CainKJ , ChapinRB , CharboneauRG , BarkeRA . Morphine modulates NF kappa B activation in macrophages . Biochem. Biophys. Res. Commun.245 ( 2 ), 392 – 396 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Sacerdote P . Effects of in vitro and in vivo opioids on the production of IL-12 and IL-10 by murine macrophages . Ann. N. Y. Acad. Sci.992 , 129 – 140 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Brown JN , OrtizGM , AngelTEet al. Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levels . Mol. Cell. Proteomics11 ( 9 ), 605 – 618 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Flores LR , WahlSM , BayerBM . Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking . J. Pharmacol. Exp. Ther.272 ( 3 ), 1246 – 1251 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Saurer TB , CarriganKA , IjamesSG , LysleDT . Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell . J. Neuroimmunol.173 ( 1–2 ), 3 – 11 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Martucci C , PaneraiAE , SacerdoteP . Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses . Pain110 ( 1–2 ), 385 – 392 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Sacerdote P , GaspaniL , RossoniG , PaneraiAE , BianchiM . Effect of the opioid remifentanil on cellular immune response in the rat . Int. Immunopharmacol.1 ( 4 ), 713 – 719 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Yardeni IZ , BeilinB , MayburdE , AlcalayY , BesslerH . Relationship between fentanyl dosage and immune function in the postoperative period . J. Opioid Manag.4 ( 1 ), 27 – 33 ( 2008 ).
   PubMedGoogle Scholar
• Cata JP , KeertyV , KeertyDet al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection . Cancer Med.3 ( 4 ), 900 – 908 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Maher DP , WongW , WhitePFet al. Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis . Br. J. Anaesth.113 ( Suppl. 1 ), i88 – i94 ( 2014 ).
   PubMedGoogle Scholar
• Forget P , TombalB , ScholtesJLet al. Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? Eur. J. Anaesthesiol. 28 ( 12 ), 830 – 835 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Singleton PA , MirzapoiazovaT , HasinaR , SalgiaR , MossJ . Increased mu-opioid receptor expression in metastatic lung cancer . Br. J. Anaesth.113 ( Suppl. 1 ), i103 - i108 ( 2014 ).
   PubMedGoogle Scholar
• Mathew B , LennonFE , SieglerJet al. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation . Anesth. Analg.112 ( 3 ), 558 – 567 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yao Y-S , YaoR-Y , ZhuangL-Ket al. MOR1 expression in gastric cancer: a biomarker associated with poor outcome . Clin. Transl. Sci.8 ( 2 ), 137 – 142 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhang YF , XuQX , LiaoLDet al. Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma . Dis. Esophagus28 ( 2 ), 196 – 203 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zylla D , GourleyBL , VangDet al. Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer . Cancer119 ( 23 ), 4103 – 4110 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Janku F , JohnsonLK , KarpDD , AtkinsJT , SingletonPA , MossJ . Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer . Ann. Oncol.27 ( 11 ), 2032 – 2038 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Tai Y-H , WuH-L , ChangW-K , TsouM-Y , ChenH-H , ChangK-Y . Intraoperative fentanyl consumption does not impact cancer recurrence or overall survival after curative colorectal cancer resection . Sci. Rep.7 ( 1 ), 10816 ( 2017 ).
   PubMedGoogle Scholar
• Cummings KC , XuF , CummingsLC , CooperGS . A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy . Anesthesiology116 ( 4 ), 797 – 806 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Christopherson R , JamesKE , TablemanM , MarshallP , JohnsonFE . Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia . Anesth. Analg.107 ( 1 ), 325 – 332 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Park WY , ThompsonJS , LeeKK . Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veterans Affairs cooperative study . Ann. Surg.234 ( 4 ), 560 – 569 ; discussion 569–571 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Kim SY , KimNK , BaikSHet al. Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer: a randomized study . Medicine (Baltimore)95 ( 19 ), e3602 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Vogelaar FJ , AbeggR , Van Der LindenJCet al. Epidural analgesia associated with better survival in colon cancer . Int. J. Colorectal Dis.30 ( 8 ), 1103 – 1107 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Myles PS , PeytonP , SilbertBet al. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial . BMJ342 , d1491 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Binczak M , TournayE , BillardV , ReyA , JayrC . Major abdominal surgery for cancer: does epidural analgesia have a long-term effect on recurrence-free and overall survival?Ann. Fr. Anesth. Reanim.32 ( 5 ), e81 – e88 ( 2013 ).
   PubMedGoogle Scholar
• Gupta A , BjornssonA , FredrikssonM , HallbookO , EintreiC . Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden . Br. J. Anaesth.107 ( 2 ), 164 – 170 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Gottschalk A , FordJG , RegelinCCet al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery . Anesthesiology113 ( 1 ), 27 – 34 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Day A , SmithR , JourdanI , FawcettW , ScottM , RockallT . Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer . Br. J. Anaesth.109 ( 2 ), 185 – 190 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Naghibzadeh-Tahami A , Yazdi FeyzabadiV , KhanjaniNet al. Can opium use contribute to a higher risk of colorectal cancers? A matched case-control study in Iran . Iran J. Public Health45 ( 10 ), 1322 – 1331 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Kimura M , IwaiM , UsamiE , TeramachiH , YoshimuraT . Prognostic factors in patients with advanced and recurrent colorectal cancer receiving last-line chemotherapy . Pharmazie73 ( 2 ), 115 – 119 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Desborough JP . The stress response to trauma and surgery . Br. J. Anaesth.85 ( 1 ), 109 – 117 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Hiller J , BrodnerG , GottschalkA . Understanding clinical strategies that may impact tumour growth and metastatic spread at the time of cancer surgery . Best Pract. Res. Clin. Anaesthesiol.27 ( 4 ), 427 – 439 ( 2013 ).
   PubMedGoogle Scholar
• Gottschalk A , SharmaS , FordJ , DurieuxME , TiouririneM . Review article: the role of the perioperative period in recurrence after cancer surgery . Anesth. Analg.110 ( 6 ), 1636 – 1643 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Horowitz M , NeemanE , SharonE , Ben-EliyahuS . Exploiting the critical perioperative period to improve long-term cancer outcomes . Nat. Rev. Clin. Oncol.12 ( 4 ), 213 – 226 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sekandarzad MW , Van ZundertAAJ , LirkPB , DoornebalCW , HollmannMW . Perioperative anesthesia care and tumor progression . Anesth. Analg.124 ( 5 ), 1697 – 1708 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Snyder GL , GreenbergS . Effect of anaesthetic technique and other perioperative factors on cancer recurrence . Br. J. Anaesth.105 ( 2 ), 106 – 115 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sessler DI . Long-term consequences of anesthetic management . Anesthesiology111 ( 1 ), 1 – 4 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Niwa H , RowbothamDJ , LambertDG , BuggyDJ . Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery?J. Anesth.27 ( 5 ), 731 – 741 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Byrne K , LevinsKJ , BuggyDJ . Can anesthetic–analgesic technique during primary cancer surgery affect recurrence or metastasis?Can. J. Anaesth.63 ( 2 ), 184 – 192 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Ash SA , BuggyDJ . Does regional anaesthesia and analgesia or opioid analgesia influence recurrence after primary cancer surgery? An update of available evidence . Best Pract. Res. Clin. Anaesthesiol.27 ( 4 ), 441 – 456 ( 2013 ).
   PubMedGoogle Scholar
• Nylund G , PetterssonA , BengtssonC , Khorram-ManeshA , NordgrenS , DelbroDS . Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon . Dig. Dis. Sci.53 ( 2 ), 461 – 466 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Zagon IS , RahnKA , MclaughlinPJ . Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells . Neuropeptides41 ( 6 ), 441 – 452 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Tegeder I , GeisslingerG . Opioids as modulators of cell death and survival--unraveling mechanisms and revealing new indications . Pharmacol. Rev.56 ( 3 ), 351 – 369 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Afsharimani B , BaranJ , WatanabeS , LindnerD , CabotPJ , ParatMO . Morphine and breast tumor metastasis: the role of matrix-degrading enzymes . Clin. Exp. Metastasis31 ( 2 ), 149 – 158 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Singleton PA , LingenMW , FeketeMJ , GarciaJG , MossJ . Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation . Microvasc. Res.72 ( 1–2 ), 3 – 11 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Fujioka N , NguyenJ , ChenCet al. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer . Anesth. Analg.113 ( 6 ), 1353 – 1364 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ecimovic P , MurrayD , DoranP , McdonaldJ , LambertDG , BuggyDJ . Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene . Br. J. Anaesth.107 ( 6 ), 916 – 923 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Farooqui M , LiY , RogersTet al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia . Br. J. Cancer97 ( 11 ), 1523 – 1531 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Liao SJ , ZhouYH , YuanYet al. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes alphavbeta3-mediated adhesion and invasive migration . Breast Cancer Res. Treat.133 ( 3 ), 853 – 863 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Doornebal CW , VrijlandK , HauCSet al. Morphine does not facilitate breast cancer progression in two preclinical mouse models for human invasive lobular and HER2(+) breast cancer . Pain156 ( 8 ), 1424 – 1432 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hooijmans CR , GeessinkFJ , Ritskes-HoitingaM , SchefferGJ . A systematic review and meta-analysis of the ability of analgesic drugs to reduce metastasis in experimental cancer models . Pain156 ( 10 ), 1835 – 1844 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Koodie L , RamakrishnanS , RoyS . Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway . Am. J. Pathol.177 ( 2 ), 984 – 997 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Khabbazi S , NassarZD , GoumonY , ParatM-O . Morphine decreases the pro-angiogenic interaction between breast cancer cells and macrophages in vitro . Sci. Rep.6 ( 1 ), 31572 ( 2016 ).
   PubMedGoogle Scholar
• Cummings KC , 3rd , XuF , CummingsLC , CooperGS . A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study . Anesthesiology116 ( 4 ), 797 – 806 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Christopherson R , JamesKE , TablemanM , MarshallP , JohnsonFE . Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia . Anesth. Analg.107 ( 1 ), 325 – 332 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Binczak M , TournayE , BillardV , ReyA , JayrC . Major abdominal surgery for cancer: does epidural analgesia have a long-term effect on recurrence-free and overall survival?Ann. Fr. Anesth. Reanim.32 ( 5 ), 8 ( 2013 ).
   Google Scholar
• Gupta A , BjornssonA , FredrikssonM , HallbookO , EintreiC . Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden . Br. J. Anaesth.107 ( 2 ), 164 – 170 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Gottschalk A , FordJ , RegelinCet al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery . Anesthesiology113 ( 1 ), 27 – 34 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Day A , SmithR , JourdanI , FawcettW , ScottM , RockallT . Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer . Br. J. Anaesth.109 ( 2 ), 185 – 190 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhang C , MuruganS , BoyadjievaN , JabbarS , ShrivastavaP , SarkarDK . Beta-endorphin cell therapy for cancer prevention . Cancer Prev. Res.8 ( 1 ), 56 – 67 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Boyadjieva NI , ChaturvediK , PoplawskiMM , SarkarDK . Opioid antagonist naltrexone disrupts feedback interaction between mu and delta opioid receptors in splenocytes to prevent alcohol inhibition of NK cell function . J. Immunol.173 ( 1 ), 42 – 49 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Buggy DJ , BorgeatA , CataJet al. Consensus statement from the BJA Workshop on Cancer and Anaesthesia . Br. J. Anaesth.114 ( 1 ), 2 – 3 ( 2015 ).
   PubMed Web of Science ®Google Scholar